1999Journal of Pediatric Gastroenterology and NutritionRequires access

Cisapride in Constipation

Yvan Vandenplas

Open publisher page 0 citations

Abstract

To the Editor: I. M. Halabi showed that cisapride may be helpful in the management of chronic idiopathic constipation in children (1). However, cisapride should not be recommended as a first-line approach in paediatric constipation. Prokinetics, or drug treatment in general, should only be recommended after failure of behavioral (physical activity) and dietary changes (Fluid, fiber, fruit) (2). Moreover, the dose of cisapride used in the study by Halabi (1.2 mg/kg/day) is 50% above the recommended safe dose of 0.8 mg/kg per day (3). If cisapride is prescribed in a dose higher than the recommended 0.8 mg/kg per day, safety procedures such as an electrocardiogram 48 to 72 hours after initiation of cisapride at a higher dose should be performed (3). Yvan Vandenplas AZ-VUB, Laarbeeklaan Brussels, Belgium

About this research paper

What this paper is about

To the Editor: I. M. Halabi showed that cisapride may be helpful in the management of chronic idiopathic constipation in children (1). However, cisapride should not be recommended as a first-line approach in paediatric constipation. Prokinetics, or drug treatment in general, should only be recommended after failure of behavioral (physical activity) and dietary changes (Fluid, fiber, fruit) (2). Moreover, the dose of cisapride used in the study by Halabi (1.2 mg/kg/day) is 50% above the recommended safe dose of 0.8 mg/kg per day (3). If cisapride is prescribed in a dose higher than the recommended 0.8 mg/kg per day, safety procedures such as an electrocardiogram 48 to 72 hours after initiation of cisapride at a higher dose should be performed (3). Yvan Vandenplas AZ-VUB, Laarbeeklaan Brussels, Belgium

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

To the Editor: I. M. Halabi showed that cisapride may be helpful in the management of chronic idiopathic constipation in children (1). However, cisapride should not be recommended as a first-line approach in paediatric constipation. Prokinetics, or drug treatment in general, should only be recommended after failure of behavioral (physical activity) and dietary changes (Fluid, fiber, fruit) (2). Moreover, the dose of cisapride used in the study by Halabi (1.2 mg/kg/day) is 50% above the recommended safe dose of 0.8 mg/kg per day (3). If cisapride is prescribed in a dose higher than the recommended 0.8 mg/kg per day, safety procedures such as an electrocardiogram 48 to 72 hours after initiation of cisapride at a higher dose should be performed (3). Yvan Vandenplas AZ-VUB, Laarbeeklaan Brussels, Belgium

Key concepts: Cisapride, Medicine, Constipation, Prokinetic agent, Drug, Internal medicine, Gastroenterology, Anesthesia

Related papers

Back to paper searchBrowse research topicsOriginal source
Cisapride in Constipation — Research Paper | ScholarLens